AZURRX BIOPHARMA, INC. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive AZURRX BIOPHARMA, INC. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement Item 1.01. Entry into a Material Definitive Agreement.
Form 424B5 AVEO PHARMACEUTICALS StreetInsider.com Warrants to Purchase up to Shares of Common Stock. •. AVEO Pharmaceuticals, Inc. is offering shares of common stock and warrants to purchase up to shares …
Form 424B5 AVEO PHARMACEUTICALS – StreetInsider.com Read More »
Karsten Cancels Outstanding Warrants Nasdaq VANCOUVER, British Columbia, April 02, 2019– Karsten Energy Corp. is pleased to announce that it has reached an agreement with warrant holders.
Karsten Cancels Outstanding Warrants – Nasdaq Read More »
President makes the smart call for reforming housing finance system | TheHill The Hill Fannie Mae and Freddie Mac need some serious changes before another financial meltdown strikes.
President makes the smart call for reforming housing finance system | TheHill – The Hill Read More »
Why Real Goods Solar, Inc. (RGSE) Stock is Down Almost -35.7% Today Find News What just happened? Real Goods Solar, Inc. (NASDAQ:RGSE) stock value has plummeted by nearly -35.7% or (-0.11 points) to $0.19 from its previous close of …
Why Real Goods Solar, Inc. (RGSE) Stock is Down Almost -35.7% Today – Find News Read More »
51 Stocks Moving In Tuesday’s Mid-Day Session Benzinga Gainers Sangamo Therapeutics Inc (NASDAQ: SGMO) shares climbed 35.1 percent to $12.87 after the company announced positive Phase 1/2 interim data for …
51 Stocks Moving In Tuesday's Mid-Day Session – Benzinga Read More »
Form 425 Precision Therapeutics Filed by: Precision Therapeutics Inc. StreetInsider.com Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. SECURITIES AND EXCHANGE COMMISSION.
TOMI Environmental Solutions, Inc. filed 10-K on Mon, April 01 | Thorold News Thorold News TOMI Environmental Solutions, Inc. files 10-K in a filing on Apr 01, 2019 accessible here.We have expanded our SteraMist® BIT™ Technology beyond the initial.
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results Benzinga SOUTH SAN FRANCISCO, Calif., April 1, 2019 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today reported financial results for the fourth …
LEAP THERAPEUTICS, INC. files 10-K | Thorold News Thorold News LEAP THERAPEUTICS, INC. files 10-K in a filing on Apr 01.Esophageal cancer, or EC, and gastric cancer, or GC, are malignancies of the digestive tract. The.
LEAP THERAPEUTICS, INC. files 10-K | Thorold News – Thorold News Read More »